The U.S. small molecule drug discovery outsourcing market, valued at USD 1.49 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 9.48% from 2025 to 2034, driven by escalating R&D costs, talent scarcity, and the pharmaceutical industry’s strategic shift toward externalized innovation. As biopharma companies face mounting pressure to accelerate drug...
The global small molecule drug discovery outsourcing market, valued at USD 4.48 billion in 2024, is anticipated to expand at a CAGR of 9.68% from 2025 to 2034, with growth increasingly driven by segment-wise performance across service types, therapeutic areas, and technological platforms. Unlike biologics development, which relies heavily on biological systems, small molecule discovery remains...
Drug Discovery Outsourcing Market: Comprehensive Overview, Trends, and Forecast
The Drug Discovery Outsourcing Market is experiencing robust expansion as pharmaceutical and biotechnology companies increasingly rely on specialized contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) to accelerate innovation, reduce costs, and...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek